OXB — Oxford BioMedica Share News
0.000.00%
- £761.50m
- £813.05m
- £128.80m
REG - Oxford Biomedica PLC - Director Dealings / Market Share Purchase
AnnouncementREG - Oxford Biomedica PLC - Block listing Interim Review
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - Director Dealings / Market Share Purchase
AnnouncementRCS - Oxford Biomedica PLC - Axovant FDA meeting feedback
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - Longer term Kymriah efficacy and safety data
AnnouncementREG - Oxford Biomedica PLC - Director Dealings
AnnouncementREG - Oxford Biomedica PLC - Oxford Biomedica form digital framework initiative
AnnouncementREG - Oxford Biomedica PLC - Block listing application
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - Axovant Doses First Patient with AXO-Lenti-PD
AnnouncementREG - Oxford Biomedica PLC - Director Dealings / Market Share Purchase
AnnouncementREG - Oxford Biomedica PLC - Details of alliance with Orchard Therapeutics
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - Director/PDMR Shareholding
AnnouncementREG - Oxford Biomedica PLC - Oxford BioMedica Interim Results
AnnouncementREG - Oxford Biomedica PLC - Oxford BioMedica further capacity expansion
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
Announcement